Imagion Biosystems Limited (ASX:IBX)
0.0290
+0.0010 (3.45%)
Sep 11, 2025, 12:38 PM AEST
Imagion Biosystems Revenue
Imagion Biosystems had revenue of 25.73K AUD in the half year ending June 30, 2025, a decrease of -96.27%. This brings the company's revenue in the last twelve months to 1.06M, down -82.15% year-over-year. In the year 2024, Imagion Biosystems had annual revenue of 2.67M, down -46.38%.
Revenue (ttm)
1.06M
Revenue Growth
-82.15%
P/S Ratio
6.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.14M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
Dec 31, 2020 | 2.70M | 206.96K | 8.31% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |